CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Postal POS
Postal Service-Issues related to proposed changes within USPS delivery schedule. S 2051-Improving Postal Operations Service & Transparency Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEATHER CUTLER | — |
Taxation/Internal Revenue Code TAX
Issues related to restructuring of corporate tax rates and Excise Tax. HR 3763-Surface Transportation Reauthorization & Reform Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILLY RAINES | — |
| MELISSA SCHULMAN New | Policy Director, Steny Hoyer |
| ANN WALKER | — |
Health Issues HCR
Issues related to smoking cessation, Medicare Part D, contraceptive coverage and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices. Issues related to Federal Employees Health Benefits Plan. HR 6-21st Century Cures Act HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEATHER CUTLER | — |
| BRIAN FILES | — |
| BILLY RAINES | — |
| MARISSA SCHLAIFER | — |
| MELISSA SCHULMAN New | Policy Director, Steny Hoyer |
| ANN WALKER | — |
Medicare/Medicaid MMM
Medicare/Medicaid-Issues related to plan design, reimbursement, audit and cost savings proposals and SGR. Issues related to Part D Prescriber enrollment. HR 793 - Ensuring Seniors Access to Local Pharmacies Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEATHER CUTLER | — |
| BRIAN FILES | — |
| MARISSA SCHLAIFER | — |
| ANN WALKER | — |
Labor Issues/Antitrust/Workplace LBR
Issues related to anti-trust and merger activity.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILLY RAINES | — |
| MELISSA SCHULMAN New | Policy Director, Steny Hoyer |
| ANN WALKER | — |
Pharmacy PHA
Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, 340B, drug pricing and drug supply chain safety & Tricare. Issues related to biosimilars, hazardous drug handling, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 1735-National Defense Authorization Act for Fiscal Year 2016 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 201
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEATHER CUTLER | — |
| BRIAN FILES | — |
| BILLY RAINES | — |
| MARISSA SCHLAIFER | — |
| MELISSA SCHULMAN New | Policy Director, Steny Hoyer |
| ANN WALKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.